• Antibody-Drug Conjugates: Transforming Breast Cancer Treatment

  • May 24 2023
  • Length: 23 mins
  • Podcast

Antibody-Drug Conjugates: Transforming Breast Cancer Treatment

  • Summary

  • The Private Cancer Physician’s Podcast series on Managing Patients with Cancer is pleased to release its new podcast: Antibody-Drug Conjugates: Transforming Breast Cancer Treatment In this podcast, we discuss antibody-drug conjugates (ADCs) and the transformative role they are playing in the fight against metastatic breast cancer. ADCs are “smart bombs” that provide a new construct to treat metastatic breast cancer, with higher efficacy and less off target toxicities. Dr Richard de Boer, Medical Oncologist from the Peter MacCallum Cancer Centre is joined by Professor Hope Rugo, Director, Breast Oncology and Clinical Trials Education and Medical Director of Cancer Infusion Services, UCSF as well as Dr Belinda Yeo, Medical Oncologist from the Austin Hospital in Melbourne, Australia, and Clinician Scientist from the Olivia Newton-John Cancer Research Institute. Produced by ScienceToLife
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Antibody-Drug Conjugates: Transforming Breast Cancer Treatment

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.